Jul 20,2022

Healthtech startup Fitterfly raises $12 million in Series A funding round

Fitterfly, a healthtech start-up has raised $12 million in Series A funding led by Amazon Smbhav Venture Fund and Fireside Ventures.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jul 21,2022

Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program

Meta Score will be the metric and digital biomarker the Company will use as part of its consumer programs. This digital biomarker will derive output from Nemaura’s glucose sensor in combination with a number of behavioral inputs of users.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jul 21,2022

DarioHealth Demonstrates Continued Growth in Multi-Chronic Contracts with Latest Addition of a National Employer for the Full Solution Suite

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its full suite of integrated chronic condition management solutions to a national employer. The new account is expected to launch in the third quarter of 2022.

View Analyst & Ambassador Comments
Go to original news
Jul 21,2022

Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary Biomedical.

COLLABORATION MERGERS & ACQUISITION

#product & service

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jul 22,2022

DigiBete and JDRF New Collaboration

The collaboration between the type 1 diabetes charity (JDRF) and the video platform and app (DigiBete) will enable both organisations to pool resources and co-create information about a broad range of subjects from daily management to nutrition and wellbeing. The content will be developed with the help of influencers, youth ambassadors and young people with type 1.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Jul 25,2022

Teladoc Health Names Mike Waters as Chief Operating Officer

Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, has named Mike Waters as chief operating officer.

View Analyst & Ambassador Comments
Go to original news
Jul 25,2022

Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study

Continuous glucose monitoring (CGM) is approved for insulin dosing decisions in the ambulatory setting, but not currently for inpatients. CGM has the capacity to reduce patient-provider contact in inpatients with coronavirus disease 2019 (COVID-19), thus potentially reducing in hospital virus transmission. However, there are sparse data on the accuracy and efficacy of CGM to titrate insulin doses in inpatients.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Jul 26,2022

Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2022 financial results after market close on Tuesday, August 9, 2022.

View Analyst & Ambassador Comments
Go to original news
Jul 26,2022

Hospital Leaders Explore the Future of Insulin Management at Glytec’s Conference on Glycemic Innovation and Collaboration

Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced details about its annual conference on glycemic management and collaboration, “Time To Target: The Future of Glycemic Management.” Attendees of this event will explore the latest trends in developing best-in-class glycemic management programs. There is no cost to attend the conference, which will be held virtually on October 25-26, 2022.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jul 26,2022

Hygieia announces new CPT codes for autonomous insulin dose titration

Hygieia, a digital therapeutics company for insulin therapy, announces the American Medical Association (AMA) CPT Editorial Panel has approved two new Category III codes for autonomous insulin dose titration, which can be used for Hygieia’s d-Nav® Technology.

PRODUCT

#dtx

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES